personalized medicine

(redirected from Personalised medicine)

personalized medicine

The study of an individual's unique biochemical and genetic makeup, in order to determine his susceptibility to disease or potential responses to treatment.
Synonym: genomic medicine, theranostics
See also: medicine
References in periodicals archive ?
PERSONALISED medicine could take 20 years to become routine in the UK's health system, an expert has warned.
Dr Steve Gardner, CEO of RowAnalytics, will tell an audience of health, medical and life sciences professionals in Cardiff this week that delivering fully personalised medicine, which involves unique treatments tailored to each patient's genetic makeup, is "incredibly complex" and resource heavy.
Cancer medicine company Inform Genomics Inc reported on Tuesday the launch of a collaboration agreement with TESARO Inc (NasdaqGS:TSRO) for genomic-based personalised medicine products.
Stating that current levels of double-digit growth are only the tip of the iceberg, Frost & Sullivan projects exponential growth for the European personalised medicine market.
The European personalised medicine market is currently growing at double-digit growth rates, which is significant especially as it comes from an already high base.
8 August 2013 - The personalised medicine and related companion diagnostic markets have significant growth opportunities and great potential for investment, Kelly Scientific Publications said in a report, published today.
Among the biggest markets for personalised medicine are the USA, the UK, Germany and France, the report noted.
It was reported today that Labceutics, a personalised medicine laboratory network in the EU, has introduced the Labceutics Connect platform.
The platform offers its network members a secure portal to share information, promote training and best practices, and discuss personalised medicine partnering opportunities.
To grow in this new era of evidence-based personalised medicine, companies should generate a sustainable product pipeline characterised by improved productivity and diversity.
List of keywords in this press release: clinical development, pharmaceuticals industry, sustainable drug pipelines, drug discovery, patent expiry, blockbuster drugs, macular degeneration, Alzheimer's disease, cancer, obesity, evidence-based treatments, personalised medicine, drug candidates, computer modelling, molecular biomarking, biological models, bioinformatics, biomarkers, high throughput screening, gene therapy, generics, generic pharmaceuticals, broad-spectrum antibiotics
The combination of this technological and market knowledge will allow GE to accelerate the development of molecular imaging and personalised medicine where it will be possible to predict and treat disease with therapies tailored to the individual.